 | • レポートコード：GIR-2104Z13751 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、治療用ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。治療用ワクチンの種類別市場規模（ペプチド治療ワクチン、細胞治療ワクチン、核酸治療ワクチン）、用途別市場規模（腫瘍療法、B型肝炎、結核、単純ヘルペスウイルス、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・治療用ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Northeast Biotherapeutics、Agenus、Vaccinogen Inc、CIMAB S.A、Dendreon、Corixa、AVAX Technologies ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ペプチド治療ワクチン、細胞治療ワクチン、核酸治療ワクチン ・用途別分析2016年-2026年：腫瘍療法、B型肝炎、結核、単純ヘルペスウイルス、その他 ・治療用ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・治療用ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・治療用ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・治療用ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・治療用ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Therapeutic Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Therapeutic Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Therapeutic Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Therapeutic Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine
Market segment by Application can be divided into
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
The key market players for global Therapeutic Vaccines market are listed below:
Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Therapeutic Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Peptide Therapeutic Vaccine
1.2.3 Cell Therapeutic Vaccine
1.2.4 Nucleic Acid Therapeutic Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncotherapy
1.3.3 Hepatitis B
1.3.4 Tuberculosis
1.3.5 Herpes Simplex Virus
1.3.6 Others
1.4 Global Therapeutic Vaccines Market Size & Forecast
1.4.1 Global Therapeutic Vaccines Sales in Value (2016-2026))
1.4.2 Global Therapeutic Vaccines Sales in Volume (2016-2026)
1.4.3 Global Therapeutic Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Therapeutic Vaccines Production Capacity Analysis
1.5.1 Global Therapeutic Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Therapeutic Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Therapeutic Vaccines Market Drivers
1.6.2 Therapeutic Vaccines Market Restraints
1.6.3 Therapeutic Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Northeast Biotherapeutics
2.1.1 Northeast Biotherapeutics Details
2.1.2 Northeast Biotherapeutics Major Business
2.1.3 Northeast Biotherapeutics Therapeutic Vaccines Product and Services
2.1.4 Northeast Biotherapeutics Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Agenus
2.2.1 Agenus Details
2.2.2 Agenus Major Business
2.2.3 Agenus Therapeutic Vaccines Product and Services
2.2.4 Agenus Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Vaccinogen Inc
2.3.1 Vaccinogen Inc Details
2.3.2 Vaccinogen Inc Major Business
2.3.3 Vaccinogen Inc Therapeutic Vaccines Product and Services
2.3.4 Vaccinogen Inc Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 CIMAB S.A
2.4.1 CIMAB S.A Details
2.4.2 CIMAB S.A Major Business
2.4.3 CIMAB S.A Therapeutic Vaccines Product and Services
2.4.4 CIMAB S.A Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Dendreon
2.5.1 Dendreon Details
2.5.2 Dendreon Major Business
2.5.3 Dendreon Therapeutic Vaccines Product and Services
2.5.4 Dendreon Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Corixa
2.6.1 Corixa Details
2.6.2 Corixa Major Business
2.6.3 Corixa Therapeutic Vaccines Product and Services
2.6.4 Corixa Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 AVAX Technologies
2.7.1 AVAX Technologies Details
2.7.2 AVAX Technologies Major Business
2.7.3 AVAX Technologies Therapeutic Vaccines Product and Services
2.7.4 AVAX Technologies Therapeutic Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Therapeutic Vaccines Sales by Manufacturer
3.1 Global Therapeutic Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Therapeutic Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Therapeutic Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Therapeutic Vaccines Manufacturer Market Share
3.4.2 Top 6 Therapeutic Vaccines Manufacturer Market Share
3.5 Global Therapeutic Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Therapeutic Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Therapeutic Vaccines Market Size by Region
4.1.1 Global Therapeutic Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Therapeutic Vaccines Revenue by Region (2016-2026)
4.2 North America Therapeutic Vaccines Revenue (2016-2026)
4.3 Europe Therapeutic Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Therapeutic Vaccines Revenue (2016-2026)
4.5 South America Therapeutic Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Therapeutic Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Therapeutic Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Therapeutic Vaccines Revenue by Type (2016-2026)
5.3 Global Therapeutic Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Therapeutic Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Therapeutic Vaccines Revenue by Application (2016-2026)
6.3 Global Therapeutic Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Therapeutic Vaccines Sales by Type (2016-2026)
7.2 North America Therapeutic Vaccines Sales by Application (2016-2026)
7.3 North America Therapeutic Vaccines Market Size by Country
7.3.1 North America Therapeutic Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Therapeutic Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Therapeutic Vaccines Sales by Type (2016-2026)
8.2 Europe Therapeutic Vaccines Sales by Application (2016-2026)
8.3 Europe Therapeutic Vaccines Market Size by Country
8.3.1 Europe Therapeutic Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Therapeutic Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Therapeutic Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Therapeutic Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Therapeutic Vaccines Market Size by Region
9.3.1 Asia-Pacific Therapeutic Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Therapeutic Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Therapeutic Vaccines Sales by Type (2016-2026)
10.2 South America Therapeutic Vaccines Sales by Application (2016-2026)
10.3 South America Therapeutic Vaccines Market Size by Country
10.3.1 South America Therapeutic Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Therapeutic Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Therapeutic Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Therapeutic Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Therapeutic Vaccines Market Size by Country
11.3.1 Middle East & Africa Therapeutic Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Therapeutic Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Therapeutic Vaccines Typical Distributors
12.3 Therapeutic Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Therapeutic Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Therapeutic Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Northeast Biotherapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Northeast Biotherapeutics Major Business
Table 5. Northeast Biotherapeutics Therapeutic Vaccines Product and Services
Table 6. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Agenus Basic Information, Manufacturing Base and Competitors
Table 8. Agenus Major Business
Table 9. Agenus Therapeutic Vaccines Product and Services
Table 10. Agenus Therapeutic Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Vaccinogen Inc Basic Information, Manufacturing Base and Competitors
Table 12. Vaccinogen Inc Major Business
Table 13. Vaccinogen Inc Therapeutic Vaccines Product and Services
Table 14. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. CIMAB S.A Basic Information, Manufacturing Base and Competitors
Table 16. CIMAB S.A Major Business
Table 17. CIMAB S.A Therapeutic Vaccines Product and Services
Table 18. CIMAB S.A Therapeutic Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Dendreon Basic Information, Manufacturing Base and Competitors
Table 20. Dendreon Major Business
Table 21. Dendreon Therapeutic Vaccines Product and Services
Table 22. Dendreon Therapeutic Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Corixa Basic Information, Manufacturing Base and Competitors
Table 24. Corixa Major Business
Table 25. Corixa Therapeutic Vaccines Product and Services
Table 26. Corixa Therapeutic Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. AVAX Technologies Basic Information, Manufacturing Base and Competitors
Table 28. AVAX Technologies Major Business
Table 29. AVAX Technologies Therapeutic Vaccines Product and Services
Table 30. AVAX Technologies Therapeutic Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Therapeutic Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Therapeutic Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Therapeutic Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Therapeutic Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Therapeutic Vaccines Production Site of Key Manufacturer
Table 36. Global Therapeutic Vaccines Sales by Region (2016-2021e) & (K Units)
Table 37. Global Therapeutic Vaccines Sales by Region (2021-2026) & (K Units)
Table 38. Global Therapeutic Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Therapeutic Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Therapeutic Vaccines Sales by Type (2016-2021e) & (K Units)
Table 41. Global Therapeutic Vaccines Sales by Type (2021-2026) & (K Units)
Table 42. Global Therapeutic Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Therapeutic Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Therapeutic Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 45. Global Therapeutic Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 46. Global Therapeutic Vaccines Sales by Application (2016-2021e) & (K Units)
Table 47. Global Therapeutic Vaccines Sales by Application (2021-2026) & (K Units)
Table 48. Global Therapeutic Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Therapeutic Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Therapeutic Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 51. Global Therapeutic Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 52. North America Therapeutic Vaccines Sales by Country (2016-2021e) & (K Units)
Table 53. North America Therapeutic Vaccines Sales by Country (2021-2026) & (K Units)
Table 54. North America Therapeutic Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Therapeutic Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Therapeutic Vaccines Sales by Type (2016-2021e) & (K Units)
Table 57. North America Therapeutic Vaccines Sales by Type (2021-2026) & (K Units)
Table 58. North America Therapeutic Vaccines Sales by Application (2016-2021e) & (K Units)
Table 59. North America Therapeutic Vaccines Sales by Application (2021-2026) & (K Units)
Table 60. Europe Therapeutic Vaccines Sales by Country (2016-2021e) & (K Units)
Table 61. Europe Therapeutic Vaccines Sales by Country (2021-2026) & (K Units)
Table 62. Europe Therapeutic Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Therapeutic Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Therapeutic Vaccines Sales by Type (2016-2021e) & (K Units)
Table 65. Europe Therapeutic Vaccines Sales by Type (2021-2026) & (K Units)
Table 66. Europe Therapeutic Vaccines Sales by Application (2016-2021e) & (K Units)
Table 67. Europe Therapeutic Vaccines Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific Therapeutic Vaccines Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific Therapeutic Vaccines Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific Therapeutic Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Therapeutic Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Therapeutic Vaccines Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific Therapeutic Vaccines Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Therapeutic Vaccines Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific Therapeutic Vaccines Sales by Application (2021-2026) & (K Units)
Table 76. South America Therapeutic Vaccines Sales by Country (2016-2021e) & (K Units)
Table 77. South America Therapeutic Vaccines Sales by Country (2021-2026) & (K Units)
Table 78. South America Therapeutic Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Therapeutic Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Therapeutic Vaccines Sales by Type (2016-2021e) & (K Units)
Table 81. South America Therapeutic Vaccines Sales by Type (2021-2026) & (K Units)
Table 82. South America Therapeutic Vaccines Sales by Application (2016-2021e) & (K Units)
Table 83. South America Therapeutic Vaccines Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa Therapeutic Vaccines Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa Therapeutic Vaccines Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa Therapeutic Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Therapeutic Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Therapeutic Vaccines Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa Therapeutic Vaccines Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Therapeutic Vaccines Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa Therapeutic Vaccines Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Therapeutic Vaccines Typical Distributors
Table 95. Therapeutic Vaccines Typical Customers
List of Figures
Figure 1. Therapeutic Vaccines Picture
Figure 2. Global Therapeutic Vaccines Sales Market Share by Type in 2020
Figure 3. Peptide Therapeutic Vaccine
Figure 4. Cell Therapeutic Vaccine
Figure 5. Nucleic Acid Therapeutic Vaccine
Figure 6. Global Therapeutic Vaccines Sales Market Share by Application in 2020
Figure 7. Oncotherapy
Figure 8. Hepatitis B
Figure 9. Tuberculosis
Figure 10. Herpes Simplex Virus
Figure 11. Others
Figure 12. Global Therapeutic Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Therapeutic Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Therapeutic Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Therapeutic Vaccines Sales (2016-2026) & (K Units)
Figure 34. Global Therapeutic Vaccines Production Capacity (2016-2026) & (K Units)
Figure 35. Global Therapeutic Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Therapeutic Vaccines Market Drivers
Figure 37. Therapeutic Vaccines Market Restraints
Figure 38. Therapeutic Vaccines Market Trends
Figure 39. Global Therapeutic Vaccines Sales Market Share by Manufacturer in 2020
Figure 40. Global Therapeutic Vaccines Revenue Market Share by Manufacturer in 2020
Figure 41. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Therapeutic Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Therapeutic Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Therapeutic Vaccines Sales Market Share by Region (2016-2026)
Figure 45. Global Therapeutic Vaccines Revenue Market Share by Region (2016-2026)
Figure 46. North America Therapeutic Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Europe Therapeutic Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Therapeutic Vaccines Revenue (2016-2026) & (USD Million)
Figure 49. South America Therapeutic Vaccines Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Therapeutic Vaccines Revenue (2016-2026) & (USD Million)
Figure 51. Global Therapeutic Vaccines Sales Market Share by Type (2016-2026)
Figure 52. Global Therapeutic Vaccines Revenue Market Share by Type (2016-2026)
Figure 53. Global Therapeutic Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Therapeutic Vaccines Sales Market Share by Application (2016-2026)
Figure 55. Global Therapeutic Vaccines Revenue Market Share by Application (2016-2026)
Figure 56. Global Therapeutic Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Therapeutic Vaccines Sales Market Share by Country (2016-2026)
Figure 58. North America Therapeutic Vaccines Revenue Market Share by Country (2016-2026)
Figure 59. North America Therapeutic Vaccines Sales Market Share by Type (2016-2026)
Figure 60. North America Therapeutic Vaccines Sales Market Share by Application (2016-2026)
Figure 61. Europe Therapeutic Vaccines Sales Market Share by Country (2016-2026)
Figure 62. Europe Therapeutic Vaccines Revenue Market Share by Country (2016-2026)
Figure 63. Europe Therapeutic Vaccines Sales Market Share by Type (2016-2026)
Figure 64. Europe Therapeutic Vaccines Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Therapeutic Vaccines Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Therapeutic Vaccines Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Therapeutic Vaccines Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Therapeutic Vaccines Sales Market Share by Application (2016-2026)
Figure 69. South America Therapeutic Vaccines Sales Market Share by Country (2016-2026)
Figure 70. South America Therapeutic Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. South America Therapeutic Vaccines Sales Market Share by Type (2016-2026)
Figure 72. South America Therapeutic Vaccines Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Therapeutic Vaccines Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Therapeutic Vaccines Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Therapeutic Vaccines Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Therapeutic Vaccines Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界のHPV治療ワクチン市場 2021：企業別、地域別、種類・用途別 The HPV Therapeutic Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界のアルコール性肝炎治療市場規模・現状・予測（2021年-2027年） Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually …
- 世界のアデノシンデアミナーゼ欠損症（ADA）治療薬市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Therapeutic Market The global Adenosine Deaminase Deficiency The…
- 世界の生物学的治療薬市場規模・現状・予測（2021年-2027年） Biologic Therapeutic Drug are used for treatment of numerous diseases and conditions, and are the most advanced therapies. Market Analysis and Insights: Global Biologic Therapeutic Drug Market The global Biologic Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX …
- 世界のループス治療市場規模・現状・予測（2021年-2027年） Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition. According to the report, one of the major drivers for this market is high prevalence rate. Market Analysis and Insights: Global Lupus Therapeutic Market The global Lupus Therapeutic market size …